PAI-1 Expression in Non-scarring Hair Loss

Northwestern University10 enrolled

Overview

This study will investigate whether subjects who suffer from hair loss have increased levels of PAI-1 compared to age-matched control subjects. The level of PAI-1 expression will be determined in subjects without hair loss and in subjects with non-scarring hair loss, including androgenetic alopecia, telogen effluvium and alopecia areata.

This study will compare the levels of PAI-1 expression in subjects with different forms of non-scarring hair loss and in these subjects vs normal age-matched controls. Hair loss subjects will have their Northwestern Memorial Hospital and Northwestern Medical Faculty Foundation medical records reviewed to ensure they meet inclusion and exclusion criteria. All subjects will have a 4 mm punch biopsy on the scalp. Tissue PAI-1 levels from scalp skin biopsies will be determined by immunohistochemical staining. Samples will be kept for approximately 15 years, after which time unused samples will be destroyed.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Androgenetic Alopecia Telogen Effluvium Alopecia Areata

Eligibility

Sex: ALLMin age: 18 YearsMax age: 60 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Age-matched control subjects who do not have a history of hair loss * A clinical and pathologic diagnosis of androgenetic alopecia, telogen effluvium, alopecia areata or normal scalp skin * All subjects must have given signed, informed consent prior to registration in study Exclusion Criteria: * History of previous hair transplantation * Current and past use of medications topically on the scalp * Clinical or pathologic diagnosis of a scarring alopecia * History of inflammatory conditions of the scalp such as psoriasis

Locations (1)

Northwestern University Department of Dermatology

Chicago, Illinois, United States

Outcomes

Primary Outcomes

PAI-1 expression level in scalp skin biopsy samples

Tissue PAI-1 expression levels will be determined by immunohistochemistry, a three-layer biotin-strepavidin system. Positive PAI-1 expression per total tissue area will be quantified using the color-picker function in imaging software.The PAI-1 expression found in normal scalps will be compared to those found in scalps with hair loss.

Time frame: Baseline

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.